Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-111492
Filing Date
2025-11-13
Accepted
2025-11-13 17:23:26
Documents
15
Effectiveness Date
2025-11-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2530759d1_s8.htm S-8 46635
2 EXHIBIT 5.1 tm2530759d1_ex5-1.htm EX-5.1 11316
3 EXHIBIT 23.2 tm2530759d1_ex23-2.htm EX-23.2 2442
4 EX-FILING FEES tm2530759d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16468
5 GRAPHIC tm2530759d1_ex5-1img001.jpg GRAPHIC 8700
  Complete submission text file 0001104659-25-111492.txt   209896

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2530759d1_ex-filingfees_htm.xml XML 5065
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-291519 | Film No.: 251479844
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)